Comparison of the effects of olpasiran and placebo on risk of coronary heart disease death, myocardial infarction (MI) or urgent coronary revascularisation
Educational Partners and Supporters
AstraZeneca has provided a sponsorship grant towards this independent programme.
(Founding Partner)
Novartis has provided with arm’s length sponsorship towards the set-up of the Lp(a) Forum. The content was developed independently by the Forum.
